Serum Calcification Propensity and Clinical Events in CKD
Patients with CKD are at high risk for cardiovascular disease, ESKD, and mortality. Vascular calcification is one pathway through which cardiovascular disease risks are increased. We hypothesized that a novel measure of serum calcification propensity is associated with cardiovascular disease events,...
Gespeichert in:
| Veröffentlicht in: | Clinical journal of the American Society of Nephrology 2019-11, Vol.14 (11), p.1562-1571 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1571 |
|---|---|
| container_issue | 11 |
| container_start_page | 1562 |
| container_title | Clinical journal of the American Society of Nephrology |
| container_volume | 14 |
| creator | Bundy, Joshua D Cai, Xuan Mehta, Rupal C Scialla, Julia J de Boer, Ian H Hsu, Chi-Yuan Go, Alan S Dobre, Mirela A Chen, Jing Rao, Panduranga S Leonard, Mary B Lash, James P Block, Geoffrey A Townsend, Raymond R Feldman, Harold I Smith, Edward R Pasch, Andreas Isakova, Tamara |
| description | Patients with CKD are at high risk for cardiovascular disease, ESKD, and mortality. Vascular calcification is one pathway through which cardiovascular disease risks are increased. We hypothesized that a novel measure of serum calcification propensity is associated with cardiovascular disease events, ESKD, and all-cause mortality among patients with CKD stages 2-4.
Among 3404 participants from the prospective, longitudinal Chronic Renal Insufficiency Cohort Study, we quantified calcification propensity as the transformation time (T
) from primary to secondary calciprotein particles, with lower T
corresponding to higher calcification propensity. We used multivariable-adjusted Cox proportional hazards regression models to assess the associations of T
with risks of adjudicated atherosclerotic cardiovascular disease events (myocardial infarction, stroke, and peripheral artery disease), adjudicated heart failure, ESKD, and mortality.
The mean T
was 313 (SD 79) minutes. Over an average 7.1 (SD 3.1) years of follow-up, we observed 571 atherosclerotic cardiovascular disease events, 633 heart failure events, 887 ESKD events, and 924 deaths. With adjustment for traditional cardiovascular disease risk factors, lower T
was significantly associated with higher risk of atherosclerotic cardiovascular disease (hazard ratio [HR] per SD lower T
, 1.14; 95% confidence interval [95% CI], 1.05 to 1.25), ESKD within 3 years from baseline (HR per SD lower T
, 1.68; 95% CI, 1.52 to 1.86), and all-cause mortality (HR per SD lower T
, 1.16; 95% CI, 1.09 to 1.24), but not heart failure (HR per SD lower T
, 1.06; 95% CI, 0.97 to 1.15). After adjustment for eGFR and 24-hour urinary protein, T
was not associated with risks of atherosclerotic cardiovascular disease, ESKD, and mortality.
Among patients with CKD stages 2-4, higher serum calcification propensity is associated with atherosclerotic cardiovascular disease events, ESKD, and all-cause mortality, but this association was not independent of kidney function.
This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_10_28_CJN04710419.mp3. |
| doi_str_mv | 10.2215/CJN.04710419 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6832040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2310295853</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-fec93848f494f13c95a61eef254eaf6b4e199d4239ad8a3030e5574b24777ceb3</originalsourceid><addsrcrecordid>eNpVkEtLxDAURoMozji6cy1durBjHjdtsxGkjs9BBRXchTRNNdJJx6QdmH9vZR7o6l74Dt-9HISOCR5TSvh5fv84xpASDETsoCHhnMcC8_fd7Q5kgA5C-MIYgFG-jwaMJDwTIIZIvBjfzaJc1dpWVqvWNi569s3cuGDbZaRcGeW1dX1UR5OFcW2IrIvyh6tDtFepOpij9Ryht-vJa34bT59u7vLLaayB4zaujBYsg6wCARVhWnCVEGMqysGoKinAECFKoEyoMlMMM2w4T6GgkKapNgUboYtV77wrZqbU_Qte1XLu7Uz5pWyUlf8TZz_lR7OQScYoBtwXnK4LfPPdmdDKmQ3a1LVypumCpIxgKnjGWY-erVDtmxC8qbZnCJa_tmVvW25s9_jJ39e28EYv-wH0wnom</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2310295853</pqid></control><display><type>article</type><title>Serum Calcification Propensity and Clinical Events in CKD</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Bundy, Joshua D ; Cai, Xuan ; Mehta, Rupal C ; Scialla, Julia J ; de Boer, Ian H ; Hsu, Chi-Yuan ; Go, Alan S ; Dobre, Mirela A ; Chen, Jing ; Rao, Panduranga S ; Leonard, Mary B ; Lash, James P ; Block, Geoffrey A ; Townsend, Raymond R ; Feldman, Harold I ; Smith, Edward R ; Pasch, Andreas ; Isakova, Tamara</creator><creatorcontrib>Bundy, Joshua D ; Cai, Xuan ; Mehta, Rupal C ; Scialla, Julia J ; de Boer, Ian H ; Hsu, Chi-Yuan ; Go, Alan S ; Dobre, Mirela A ; Chen, Jing ; Rao, Panduranga S ; Leonard, Mary B ; Lash, James P ; Block, Geoffrey A ; Townsend, Raymond R ; Feldman, Harold I ; Smith, Edward R ; Pasch, Andreas ; Isakova, Tamara ; CRIC Study Investigators ; the CRIC Study Investigators</creatorcontrib><description>Patients with CKD are at high risk for cardiovascular disease, ESKD, and mortality. Vascular calcification is one pathway through which cardiovascular disease risks are increased. We hypothesized that a novel measure of serum calcification propensity is associated with cardiovascular disease events, ESKD, and all-cause mortality among patients with CKD stages 2-4.
Among 3404 participants from the prospective, longitudinal Chronic Renal Insufficiency Cohort Study, we quantified calcification propensity as the transformation time (T
) from primary to secondary calciprotein particles, with lower T
corresponding to higher calcification propensity. We used multivariable-adjusted Cox proportional hazards regression models to assess the associations of T
with risks of adjudicated atherosclerotic cardiovascular disease events (myocardial infarction, stroke, and peripheral artery disease), adjudicated heart failure, ESKD, and mortality.
The mean T
was 313 (SD 79) minutes. Over an average 7.1 (SD 3.1) years of follow-up, we observed 571 atherosclerotic cardiovascular disease events, 633 heart failure events, 887 ESKD events, and 924 deaths. With adjustment for traditional cardiovascular disease risk factors, lower T
was significantly associated with higher risk of atherosclerotic cardiovascular disease (hazard ratio [HR] per SD lower T
, 1.14; 95% confidence interval [95% CI], 1.05 to 1.25), ESKD within 3 years from baseline (HR per SD lower T
, 1.68; 95% CI, 1.52 to 1.86), and all-cause mortality (HR per SD lower T
, 1.16; 95% CI, 1.09 to 1.24), but not heart failure (HR per SD lower T
, 1.06; 95% CI, 0.97 to 1.15). After adjustment for eGFR and 24-hour urinary protein, T
was not associated with risks of atherosclerotic cardiovascular disease, ESKD, and mortality.
Among patients with CKD stages 2-4, higher serum calcification propensity is associated with atherosclerotic cardiovascular disease events, ESKD, and all-cause mortality, but this association was not independent of kidney function.
This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_10_28_CJN04710419.mp3.</description><identifier>ISSN: 1555-9041</identifier><identifier>EISSN: 1555-905X</identifier><identifier>DOI: 10.2215/CJN.04710419</identifier><identifier>PMID: 31658949</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Aged ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - etiology ; Cohort Studies ; Female ; Hematologic Tests ; Humans ; Male ; Middle Aged ; Original ; Renal Insufficiency, Chronic - blood ; Renal Insufficiency, Chronic - complications ; Vascular Calcification - complications ; Vascular Calcification - etiology</subject><ispartof>Clinical journal of the American Society of Nephrology, 2019-11, Vol.14 (11), p.1562-1571</ispartof><rights>Copyright © 2019 by the American Society of Nephrology.</rights><rights>Copyright © 2019 by the American Society of Nephrology 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-fec93848f494f13c95a61eef254eaf6b4e199d4239ad8a3030e5574b24777ceb3</citedby><cites>FETCH-LOGICAL-c450t-fec93848f494f13c95a61eef254eaf6b4e199d4239ad8a3030e5574b24777ceb3</cites><orcidid>0000-0002-9059-9998 ; 0000-0002-6054-2624 ; 0000-0001-8182-1238 ; 0000-0003-1707-691 ; 0000-0003-1707-691X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832040/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832040/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31658949$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bundy, Joshua D</creatorcontrib><creatorcontrib>Cai, Xuan</creatorcontrib><creatorcontrib>Mehta, Rupal C</creatorcontrib><creatorcontrib>Scialla, Julia J</creatorcontrib><creatorcontrib>de Boer, Ian H</creatorcontrib><creatorcontrib>Hsu, Chi-Yuan</creatorcontrib><creatorcontrib>Go, Alan S</creatorcontrib><creatorcontrib>Dobre, Mirela A</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Rao, Panduranga S</creatorcontrib><creatorcontrib>Leonard, Mary B</creatorcontrib><creatorcontrib>Lash, James P</creatorcontrib><creatorcontrib>Block, Geoffrey A</creatorcontrib><creatorcontrib>Townsend, Raymond R</creatorcontrib><creatorcontrib>Feldman, Harold I</creatorcontrib><creatorcontrib>Smith, Edward R</creatorcontrib><creatorcontrib>Pasch, Andreas</creatorcontrib><creatorcontrib>Isakova, Tamara</creatorcontrib><creatorcontrib>CRIC Study Investigators</creatorcontrib><creatorcontrib>the CRIC Study Investigators</creatorcontrib><title>Serum Calcification Propensity and Clinical Events in CKD</title><title>Clinical journal of the American Society of Nephrology</title><addtitle>Clin J Am Soc Nephrol</addtitle><description>Patients with CKD are at high risk for cardiovascular disease, ESKD, and mortality. Vascular calcification is one pathway through which cardiovascular disease risks are increased. We hypothesized that a novel measure of serum calcification propensity is associated with cardiovascular disease events, ESKD, and all-cause mortality among patients with CKD stages 2-4.
Among 3404 participants from the prospective, longitudinal Chronic Renal Insufficiency Cohort Study, we quantified calcification propensity as the transformation time (T
) from primary to secondary calciprotein particles, with lower T
corresponding to higher calcification propensity. We used multivariable-adjusted Cox proportional hazards regression models to assess the associations of T
with risks of adjudicated atherosclerotic cardiovascular disease events (myocardial infarction, stroke, and peripheral artery disease), adjudicated heart failure, ESKD, and mortality.
The mean T
was 313 (SD 79) minutes. Over an average 7.1 (SD 3.1) years of follow-up, we observed 571 atherosclerotic cardiovascular disease events, 633 heart failure events, 887 ESKD events, and 924 deaths. With adjustment for traditional cardiovascular disease risk factors, lower T
was significantly associated with higher risk of atherosclerotic cardiovascular disease (hazard ratio [HR] per SD lower T
, 1.14; 95% confidence interval [95% CI], 1.05 to 1.25), ESKD within 3 years from baseline (HR per SD lower T
, 1.68; 95% CI, 1.52 to 1.86), and all-cause mortality (HR per SD lower T
, 1.16; 95% CI, 1.09 to 1.24), but not heart failure (HR per SD lower T
, 1.06; 95% CI, 0.97 to 1.15). After adjustment for eGFR and 24-hour urinary protein, T
was not associated with risks of atherosclerotic cardiovascular disease, ESKD, and mortality.
Among patients with CKD stages 2-4, higher serum calcification propensity is associated with atherosclerotic cardiovascular disease events, ESKD, and all-cause mortality, but this association was not independent of kidney function.
This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_10_28_CJN04710419.mp3.</description><subject>Aged</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Hematologic Tests</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Renal Insufficiency, Chronic - blood</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Vascular Calcification - complications</subject><subject>Vascular Calcification - etiology</subject><issn>1555-9041</issn><issn>1555-905X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLxDAURoMozji6cy1durBjHjdtsxGkjs9BBRXchTRNNdJJx6QdmH9vZR7o6l74Dt-9HISOCR5TSvh5fv84xpASDETsoCHhnMcC8_fd7Q5kgA5C-MIYgFG-jwaMJDwTIIZIvBjfzaJc1dpWVqvWNi569s3cuGDbZaRcGeW1dX1UR5OFcW2IrIvyh6tDtFepOpij9Ryht-vJa34bT59u7vLLaayB4zaujBYsg6wCARVhWnCVEGMqysGoKinAECFKoEyoMlMMM2w4T6GgkKapNgUboYtV77wrZqbU_Qte1XLu7Uz5pWyUlf8TZz_lR7OQScYoBtwXnK4LfPPdmdDKmQ3a1LVypumCpIxgKnjGWY-erVDtmxC8qbZnCJa_tmVvW25s9_jJ39e28EYv-wH0wnom</recordid><startdate>20191107</startdate><enddate>20191107</enddate><creator>Bundy, Joshua D</creator><creator>Cai, Xuan</creator><creator>Mehta, Rupal C</creator><creator>Scialla, Julia J</creator><creator>de Boer, Ian H</creator><creator>Hsu, Chi-Yuan</creator><creator>Go, Alan S</creator><creator>Dobre, Mirela A</creator><creator>Chen, Jing</creator><creator>Rao, Panduranga S</creator><creator>Leonard, Mary B</creator><creator>Lash, James P</creator><creator>Block, Geoffrey A</creator><creator>Townsend, Raymond R</creator><creator>Feldman, Harold I</creator><creator>Smith, Edward R</creator><creator>Pasch, Andreas</creator><creator>Isakova, Tamara</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9059-9998</orcidid><orcidid>https://orcid.org/0000-0002-6054-2624</orcidid><orcidid>https://orcid.org/0000-0001-8182-1238</orcidid><orcidid>https://orcid.org/0000-0003-1707-691</orcidid><orcidid>https://orcid.org/0000-0003-1707-691X</orcidid></search><sort><creationdate>20191107</creationdate><title>Serum Calcification Propensity and Clinical Events in CKD</title><author>Bundy, Joshua D ; Cai, Xuan ; Mehta, Rupal C ; Scialla, Julia J ; de Boer, Ian H ; Hsu, Chi-Yuan ; Go, Alan S ; Dobre, Mirela A ; Chen, Jing ; Rao, Panduranga S ; Leonard, Mary B ; Lash, James P ; Block, Geoffrey A ; Townsend, Raymond R ; Feldman, Harold I ; Smith, Edward R ; Pasch, Andreas ; Isakova, Tamara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-fec93848f494f13c95a61eef254eaf6b4e199d4239ad8a3030e5574b24777ceb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Hematologic Tests</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Renal Insufficiency, Chronic - blood</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Vascular Calcification - complications</topic><topic>Vascular Calcification - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bundy, Joshua D</creatorcontrib><creatorcontrib>Cai, Xuan</creatorcontrib><creatorcontrib>Mehta, Rupal C</creatorcontrib><creatorcontrib>Scialla, Julia J</creatorcontrib><creatorcontrib>de Boer, Ian H</creatorcontrib><creatorcontrib>Hsu, Chi-Yuan</creatorcontrib><creatorcontrib>Go, Alan S</creatorcontrib><creatorcontrib>Dobre, Mirela A</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Rao, Panduranga S</creatorcontrib><creatorcontrib>Leonard, Mary B</creatorcontrib><creatorcontrib>Lash, James P</creatorcontrib><creatorcontrib>Block, Geoffrey A</creatorcontrib><creatorcontrib>Townsend, Raymond R</creatorcontrib><creatorcontrib>Feldman, Harold I</creatorcontrib><creatorcontrib>Smith, Edward R</creatorcontrib><creatorcontrib>Pasch, Andreas</creatorcontrib><creatorcontrib>Isakova, Tamara</creatorcontrib><creatorcontrib>CRIC Study Investigators</creatorcontrib><creatorcontrib>the CRIC Study Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bundy, Joshua D</au><au>Cai, Xuan</au><au>Mehta, Rupal C</au><au>Scialla, Julia J</au><au>de Boer, Ian H</au><au>Hsu, Chi-Yuan</au><au>Go, Alan S</au><au>Dobre, Mirela A</au><au>Chen, Jing</au><au>Rao, Panduranga S</au><au>Leonard, Mary B</au><au>Lash, James P</au><au>Block, Geoffrey A</au><au>Townsend, Raymond R</au><au>Feldman, Harold I</au><au>Smith, Edward R</au><au>Pasch, Andreas</au><au>Isakova, Tamara</au><aucorp>CRIC Study Investigators</aucorp><aucorp>the CRIC Study Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum Calcification Propensity and Clinical Events in CKD</atitle><jtitle>Clinical journal of the American Society of Nephrology</jtitle><addtitle>Clin J Am Soc Nephrol</addtitle><date>2019-11-07</date><risdate>2019</risdate><volume>14</volume><issue>11</issue><spage>1562</spage><epage>1571</epage><pages>1562-1571</pages><issn>1555-9041</issn><eissn>1555-905X</eissn><abstract>Patients with CKD are at high risk for cardiovascular disease, ESKD, and mortality. Vascular calcification is one pathway through which cardiovascular disease risks are increased. We hypothesized that a novel measure of serum calcification propensity is associated with cardiovascular disease events, ESKD, and all-cause mortality among patients with CKD stages 2-4.
Among 3404 participants from the prospective, longitudinal Chronic Renal Insufficiency Cohort Study, we quantified calcification propensity as the transformation time (T
) from primary to secondary calciprotein particles, with lower T
corresponding to higher calcification propensity. We used multivariable-adjusted Cox proportional hazards regression models to assess the associations of T
with risks of adjudicated atherosclerotic cardiovascular disease events (myocardial infarction, stroke, and peripheral artery disease), adjudicated heart failure, ESKD, and mortality.
The mean T
was 313 (SD 79) minutes. Over an average 7.1 (SD 3.1) years of follow-up, we observed 571 atherosclerotic cardiovascular disease events, 633 heart failure events, 887 ESKD events, and 924 deaths. With adjustment for traditional cardiovascular disease risk factors, lower T
was significantly associated with higher risk of atherosclerotic cardiovascular disease (hazard ratio [HR] per SD lower T
, 1.14; 95% confidence interval [95% CI], 1.05 to 1.25), ESKD within 3 years from baseline (HR per SD lower T
, 1.68; 95% CI, 1.52 to 1.86), and all-cause mortality (HR per SD lower T
, 1.16; 95% CI, 1.09 to 1.24), but not heart failure (HR per SD lower T
, 1.06; 95% CI, 0.97 to 1.15). After adjustment for eGFR and 24-hour urinary protein, T
was not associated with risks of atherosclerotic cardiovascular disease, ESKD, and mortality.
Among patients with CKD stages 2-4, higher serum calcification propensity is associated with atherosclerotic cardiovascular disease events, ESKD, and all-cause mortality, but this association was not independent of kidney function.
This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_10_28_CJN04710419.mp3.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>31658949</pmid><doi>10.2215/CJN.04710419</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-9059-9998</orcidid><orcidid>https://orcid.org/0000-0002-6054-2624</orcidid><orcidid>https://orcid.org/0000-0001-8182-1238</orcidid><orcidid>https://orcid.org/0000-0003-1707-691</orcidid><orcidid>https://orcid.org/0000-0003-1707-691X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1555-9041 |
| ispartof | Clinical journal of the American Society of Nephrology, 2019-11, Vol.14 (11), p.1562-1571 |
| issn | 1555-9041 1555-905X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6832040 |
| source | MEDLINE; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | Aged Cardiovascular Diseases - blood Cardiovascular Diseases - etiology Cohort Studies Female Hematologic Tests Humans Male Middle Aged Original Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - complications Vascular Calcification - complications Vascular Calcification - etiology |
| title | Serum Calcification Propensity and Clinical Events in CKD |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A30%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20Calcification%20Propensity%20and%20Clinical%20Events%20in%20CKD&rft.jtitle=Clinical%20journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Bundy,%20Joshua%20D&rft.aucorp=CRIC%20Study%20Investigators&rft.date=2019-11-07&rft.volume=14&rft.issue=11&rft.spage=1562&rft.epage=1571&rft.pages=1562-1571&rft.issn=1555-9041&rft.eissn=1555-905X&rft_id=info:doi/10.2215/CJN.04710419&rft_dat=%3Cproquest_pubme%3E2310295853%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2310295853&rft_id=info:pmid/31658949&rfr_iscdi=true |